C84.67

Clinical Causes: Genetic mutations: Specifically, the rearrangement of the ALK gene, which leads to abnormal cell growth. Cellular changes: The abnormal activation of the ALK gene causes uncontrolled proliferation of lymphoid cells. Possible environmental factors: Although not proven, some research suggests exposure to certain chemicals or infections may play a role. Age factor: It is more common in children and young adults, but can occur at any age.

Key Symptoms: Swelling or enlargement of the spleen (splenomegaly), often felt as a fullness or pain in the upper left abdomen. Persistent fever that isn't caused by infection. Unexplained weight loss over a short period. Night sweats and fatigue. Enlargement of lymph nodes in the neck, armpits, or groin. Feeling of general malaise or tiredness. Possible anemia, leading to pallor or weakness.

Diagnosis Path: Blood tests: To assess overall health and look for signs of disease. Imaging studies: Ultrasound, CT scans, or PET scans to visualize the spleen and other involved areas. Lymph node or spleen biopsy: Removal of a tissue sample for microscopic examination. Immunohistochemistry: To detect specific markers like ALK protein expression in cancer cells. Genetic testing: Identifies ALK gene rearrangements confirming the ALK-positive subtype.

Treatment Protocols: Chemotherapy: The primary treatment aimed at destroying cancer cells, typically involving regimens like CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone). Targeted therapies: Such as ALK inhibitors (e.g., crizotinib) specifically designed to target abnormal ALK proteins. Radiation therapy: May be used in localized disease or to improve symptoms. Stem cell transplantation: Considered in cases where initial treatments are not effective or for relapsed disease. Supportive care: Managing symptoms and boosting overall health through medications, nutrition, and supportive therapies.